SpayVac
Madison, US · 2 known investors
Find your way into SpayVac
SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish. The company targets livestock producers seeking to reduce handling stress and labor while maintaining animal welfare and productivity.
Founders & leadership
TD
Thomas D'OrazioinExecutiveHe has over 20 years of experience in strategic operations, product management, and business development, including prior work leading a publicly-traded entity.
MF
Mark FrakerinVP – OperationsMark Fraker brings experience in wildlife ecology and immunocontraception, with prior roles as a contractor, petroleum industry environmental scientist, and government manager, as well as university-level teaching in marine mammal ecology. He now leads operations at SpayVac, which develops single-dose fertility management vaccines for livestock.
UB
Ursula BechertinVP – Research & DevelopmentUrsula Bechert has held academic leadership positions spanning over 25 years, with expertise in veterinary medicine including small animal, exotic, and wildlife practice, as well as extensive experience developing educational programs in zoo medicine and wildlife rehabilitation.
T
TomCEO
T
TinainChief Operating OfficerTina has over 20 years of experience in operations and program management, including leadership roles in global nutrition and public health initiatives where she scaled operations across multiple countries in Africa, Latin America, and Asia.
Board
JR
Jeffrey RusinowBoard director
JP
Jeff PetersonChairman
Investors · 2
Reported raises · per SEC filings
Form D private placements$426.2K disclosed across 1 round · 2025
▶$426.2KraisedMay 2025 · 9 investors · Other Health CareRule 506(b)
▶$426.2KraisedMay 2025 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas D'OrazioExecutive Officer, Director
- Jeffrey RusinowDirector
- Mark FrakerExecutive Officer
- Jeff PetersonDirector
- Ursula BechertExecutive Officer
- Offering amount
- $1M
- Amount sold
- $426.2K
- First sale
- May 2025
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does SpayVac do?
- SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish. The company targets livestock producers seeking to reduce handling stress and labor while maintaining animal welfare and productivity.
- Who are SpayVac's investors?
- SpayVac's investors include Central Texas Angel Network, Serra Ventures.
- How much funding has SpayVac raised?
- SpayVac has disclosed $426.2K raised across 1 round.
- Where is SpayVac headquartered?
- SpayVac is headquartered in Madison, US.